J Bone Metab.  2017 Feb;24(1):59-63. 10.11005/jbm.2017.24.1.59.

Characteristics of Patients Diagnosed with Osteoporosis in South Korea: Results from the National Claim Registry

• Yoon HK
• Lee YK
• Ha YC

• KMID: 2371833
• DOI: http://doi.org/10.11005/jbm.2017.24.1.59

Abstract

BACKGROUND
Although osteoporosis is increasing medical issue in the elderly population, attempts to analyze the characteristics of patients diagnosed with osteoporosis are rare in South Korea. We investigated the characteristics of patients diagnosed with osteoporosis using Korea's National Health Insurance claims data, which includes almost Korean population.
METHODS
We evaluated the patients who were diagnosed and treated with osteoporosis in medical institute in South Korea, using the national database by the Health Insurance Review & Assessment Service (HIRA). We evaluated the characteristic of patients and state of medical service utilization in 2010.
RESULTS
The number of patients who were diagnosed with osteoporosis were 1,733,685, and almost of them (91.1%) were females. Fourteen point three percent of the patients had experienced osteoporosis-related fracture. The most commonly used type of institute and department was hospital and orthopedic surgery.
CONCLUSIONS
Considering increasing age population, basic information including characteristic of patients and current state of medical service utilization could be useful to perform appropriate management and treatment for osteoporosis patients in South Korea, using the National Health Insurance claims data.

Keyword

National health programs; Osteoporosis; Osteoporotic fractures; Republic of Korea

MeSH Terms

Aged
Female
Humans
Insurance, Health
Korea*
National Health Programs
Orthopedics
Osteoporosis*
Osteoporotic Fractures
Republic of Korea

Reference

1. Rapado I, Shulman LE, Fleisch HA, et al. Consensus development conference: diagnosis, prophylaxis, and treatment of osteoporosis. Am J Med. 1993; 94:646–650. PMID: 8506892.

2. National Institutes of Health. NIH consensus development panel on osteoporosis prevention, diagnosis, and therapy, March 7-29, 2000: highlights of the conference. South Med J. 2001; 94:569–573. PMID: 11440324.

3. Reginster JY, Burlet N. Osteoporosis: a still increasing prevalence. Bone. 2006; 38:S4–S9. PMID: 16455317.

4. Johnell O, Kanis J. Epidemiology of osteoporotic fractures. Osteoporos Int. 2005; 16(Suppl 2):S3–S7. PMID: 15365697.

5. Borgström F, Sobocki P, Ström O, et al. The societal burden of osteoporosis in Sweden. Bone. 2007; 40:1602–1609. PMID: 17433804.

6. Delmas PD. Treatment of postmenopausal osteoporosis. Lancet. 2002; 359:2018–2026. PMID: 12076571.

7. Cooper C, Campion G, Melton LJ 3rd. Hip fractures in the elderly: a world-wide projection. Osteoporos Int. 1992; 2:285–289. PMID: 1421796.

8. Gullberg B, Johnell O, Kanis JA. World-wide projections for hip fracture. Osteoporos Int. 1997; 7:407–413. PMID: 9425497.

9. Lau EM, Lee JK, Suriwongpaisal P, et al. The incidence of hip fracture in four Asian countries: the Asian Osteoporosis Study (AOS). Osteoporos Int. 2001; 12:239–243. PMID: 11315243.

10. Hagino H, Katagiri H, Okano T, et al. Increasing incidence of hip fracture in Tottori Prefecture, Japan: trend from 1986 to 2001. Osteoporos Int. 2005; 16:1963–1968. PMID: 16133645.

11. Yoon HK, Park C, Jang S, et al. Incidence and mortality following hip fracture in Korea. J Korean Med Sci. 2011; 26:1087–1092. PMID: 21860561.

12. Seo GH, Lee YK, Ha YC. Risk of hip fractures in men with alpha-blockers: a nationwide study base on claim registry. J Bone Metab. 2015; 22:29–32. PMID: 25774362.

13. Seo GH, Choi HJ. Oral bisphosphonate and risk of esophageal cancer: a nationwide claim study. J Bone Metab. 2015; 22:77–81. PMID: 26082917.

14. Park C, Jang S, Lee A, et al. Incidence and mortality after proximal humerus fractures over 50 years of age in South Korea: national claim data from 2008 to 2012. J Bone Metab. 2015; 22:17–21. PMID: 25774360.

15. Kim SH, Ko YB, Lee YK, et al. National utilization of calcium supplements in patients with osteoporotic hip fracture in Korea. J Bone Metab. 2013; 20:99–103. PMID: 24524065.

16. Lee YK, Ha YC, Yoon BH, et al. National trends of hip arthroscopy in Korea. J Korean Med Sci. 2014; 29:277–280. PMID: 24550658.

17. Jang S, Park C, Jang S, et al. Medical service utilization with osteoporosis. Endocrinol Metab. 2010; 25:326–339.

18. Park C, Ha YC, Jang S, et al. The incidence and residual lifetime risk of osteoporosis-related fractures in Korea. J Bone Miner Metab. 2011; 29:744–751. PMID: 21644058.

19. Yoo JH, Moon SH, Ha YC, et al. Osteoporotic fracture: 2015 position statement of the Korean society for bone and mineral research. J Bone Metab. 2015; 22:175–181. PMID: 26713308.

20. Lee YK, Ha YC, Choi HJ, et al. Bisphosphonate use and subsequent hip fracture in South Korea. Osteoporos Int. 2013; 24:2887–2892. PMID: 23681088.

21. Park EJ, Joo IW, Jang MJ, et al. Prevalence of osteoporosis in the Korean population based on Korea National Health and Nutrition Examination Survey (KNHANES), 2008-2011. Yonsei Med J. 2014; 55:1049–1057. PMID: 24954336.

22. Ministry of Health & Welfare. Korea Centers for Disease Control & Prevention. Korea health statistics 2009: Korea national health and nutrition examination survey (KNHANES IV-3). Seoul: Ministry of Health & Welfare;2010.